Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

Many diabetic patients continue to have hyperglycaemia on maximal sulphonylurea therapy. Five different therapeutic options, with the prime aim of achieving normal fasting plasma glucose concentrations, have been compared in 15 asymptomatic, sulphonylurea-treated type 2 diabetic patients in a random...

書目詳細資料
Main Authors:	Holman, R, Steemson, J, Turner, R
格式:	Journal article
語言:	English
出版:	1987

相似書籍

TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
由: Holman, R, et al.
出版: (1987)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
由: Rachman, J, et al.
出版: (1996)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
由: Matthews, DR, et al.
出版: (1998)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
由: Eeley, E, et al.
出版: (1996)

COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
由: Holman, R, et al.
出版: (1977)

Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.
由: Holman, R, et al.
出版: (1991)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
由: Cull, C, et al.
出版: (2000)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
由: Matthews, DR, et al.
出版: (1998)

NASAL INSULIN OUTPATIENT STUDY IN TYPE-I DIABETES
由: Holman, R, et al.
出版: (1992)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
由: Eeley, E, et al.
出版: (1996)

This house believes that sulphonylureas should not be used routinely as second-line treatments for patients with type 2 diabetes
由: Ryder, R, et al.
出版: (2016)

Sulphonylureas in the management of type 2 diabetes: To be or not to be?
由: André J. Scheen
出版: (2021-01-01)

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.
由: Turner, R, et al.
出版: (1976)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
由: Turner, R, et al.
出版: (1998)

TIMING OF NASAL INSULIN DELIVERY IN TYPE-I DIABETES
由: Holman, R, et al.
出版: (1993)

Permanent neonatal diabetes: combining sulphonylureas with insulin may be an effective treatment
由: Misra, S, et al.
出版: (2018)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
由: Holman, R, et al.
出版: (1979)

Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
由: Farmer, A, et al.
出版: (2011)

LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
由: Holman, R, et al.
出版: (1984)

Sulphonylurea therapy over six years does not delay progression to diabetes
由: Herlihy, O, et al.
出版: (2000)

HUMAN ULTRALENTE INSULIN
由: Holman, R, et al.
出版: (1983)

Intermediate acting insulin for type 2 diabetes.
由: Turner, R, et al.
出版: (1985)

Factors influencing utilization of different types of sulphonylureas amongst type 2 diabetes patients
由: Huri, H.Z., et al.
出版: (2010)

Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes.
由: Evans, R, et al.
出版: (1982)

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
由: Holman, R, et al.
出版: (2007)

Sulphonylureas and hypoglycaemia.
由: Ferner, R, et al.
出版: (1988)

A practical guide to basal and prandial insulin therapy.
由: Holman, R, et al.
出版: (1985)

Human ultralente insulin.
由: Holman, R, et al.
出版: (1984)

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
由: Turner, R, et al.
出版: (1979)

Insulin therapy in type II diabetes.
由: Holman, R, et al.
出版: (1995)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
由: Cull, C, et al.
出版: (1995)

Identification of First Case of Neonatal Diabetes in Singapore and Successful Conversion from Insulin to Sulphonylurea
由: Rashida Vasanwala MD (Paeds), MRCPCH (UK), et al.
出版: (2010-06-01)

Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus
由: Fournier, Marie, et al.
出版: (2014-10-01)

Diabetes: The quest for basal normoglycaemia.
由: Holman, R, et al.
出版: (1977)

2-YEAR PROSPECTIVE-STUDY OF IMPROVED DIABETIC CONTROL IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH BACKGROUND RETINOPATHY
由: Holman, R, et al.
出版: (1982)

Rapid restoration of normoglycaemia using intravenous insulin boluses.
由: Dunnett, J, et al.
出版: (1990)

Basal insulin therapy in type 2 diabetes.
由: Bethel, M, et al.
出版: (2005)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
由: Rodrigo Oliveira Moreira, et al.
出版: (2018-04-01)

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes
由: Dario Giugliano, et al.
出版: (2012-06-01)

Pharmacogenetics in Type 2 diabetes: variation in TCF7L2 influences response to sulphonylureas
由: Pearson, E, et al.
出版: (2007)